March 15, 2017

Myomo Launches Initial Public Offering via Jobs Act Regulation A+

Myomo, Inc., a commercial stage medical robotics Company, today announced a Regulation A+ initial public offering that allows any investor the opportunity to invest in the Company’s vision for expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo’s non-invasive technology, exclusively licensed from Massachusetts Institute of Technology, restores a patient’s ability to use their partially paralyzed or weakened arms and hands again so that they can return to work, live independently and reduce their cost of care.

Read the press release here

Connect With Us

Blog Facebook LinkedIn Twitter